These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18199733)

  • 1. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study.
    Borugian MJ; Spinelli JJ; Sun Z; Kolonel LN; Oakley-Girvan I; Pollak MD; Whittemore AS; Wu AH; Gallagher RP
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):252-4. PubMed ID: 18199733
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
    Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk.
    Nam RK; Trachtenberg J; Jewett MA; Toi A; Evans A; Emami M; Narod SA; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1270-3. PubMed ID: 15894684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
    Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin-like growth factor (IGF-1) and the clinical course of prostate cancer, benign hyperplasia and prostatic intraepithelial neoplasia].
    Povelitsa EA; Nabyrov EA
    Vopr Onkol; 2008; 54(5):596-601. PubMed ID: 19069473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
    Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Null association between insulin-like growth factors, insulin-like growth factor-binding proteins, and prostate cancer in a prospective study.
    Lacey JV; Hsing AW; Fillmore CM; Hoffman S; Helzlsouer KJ; Comstock GW
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1101-2. PubMed ID: 11588138
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel insights into the implication of the IGF-1 network in prostate cancer.
    Papatsoris AG; Karamouzis MV; Papavassiliou AG
    Trends Mol Med; 2005 Feb; 11(2):52-5. PubMed ID: 15694866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin-like factor of growth (IGFI), insulin-like growth factor binding protein 3 (IGFBP3) and transforming growth factor beta1 (TGF-beta1) in patients with locally-advanced and metastatic cancer of prostate].
    Povelitsa EA
    Vopr Onkol; 2007; 53(5):544-8. PubMed ID: 18154118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I.
    Kawada M; Inoue H; Arakawa M; Ikeda D
    Anticancer Res; 2008; 28(2A):721-30. PubMed ID: 18507013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I.
    Chu LW; Zhu Y; Yu K; Zheng T; Chokkalingam AP; Stanczyk FZ; Gao YT; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3268-73. PubMed ID: 18990770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of insulin-like growth factor-I for prostate cancer therapies.
    Kojima S; Inahara M; Suzuki H; Ichikawa T; Furuya Y
    Int J Urol; 2009 Feb; 16(2):161-7. PubMed ID: 19183230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
    Vatten LJ; Holly JM; Gunnell D; Tretli S
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2097-100. PubMed ID: 18708402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening?
    Wolk A; Andersson SO; Mantzoros CS; Trichopoulos D; Adami HO
    Lancet; 2000 Dec; 356(9245):1902-3. PubMed ID: 11130391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making sense of PSA.
    Thompson IM
    Health News; 2001 Apr; 7(4):3. PubMed ID: 11303477
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma insulin-like growth factor I is inversely associated with colorectal adenoma recurrence: a novel hypothesis.
    Jacobs ET; Martínez ME; Alberts DS; Ashbeck EL; Gapstur SM; Lance P; Thompson PA
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):300-5. PubMed ID: 18250342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.
    Johansson M; McKay JD; Wiklund F; Rinaldi S; Hallmans G; Bälter K; Adami HO; Grönberg H; Stattin P; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1644-50. PubMed ID: 19423539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies.
    Chan JM; Stampfer MJ; Giovannucci E; Ma J; Pollak M
    Growth Horm IGF Res; 2000 Apr; 10 Suppl A():S32-3. PubMed ID: 10984284
    [No Abstract]   [Full Text] [Related]  

  • 20. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
    Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
    J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.